Departments of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China
Abstract： Objective To investigate the mobidity and risk factors for primary hypothyroidism (HT) in nasopharyngeal cancer (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Methods 113 NPC patients with complete clinical information who received IMRT from 2008-2010 were retrospectively analyzed. Thyroid function assessments before and after IMRT were periodically monitored. Various clinical and dosimetric parameters were obtained including Dmin,Dmax,Dmean,V30,V35,V40,V45,V50,V55,V60,V65,V70(thyroid gland), PDmin,PDmax,PDmean(pituitary gland).Univariate and multivariate logistic regression analyses were performed to identify predictors of HT. Results After a median follow-up period of 62 months,41 patients (36.3%) had clinical HT,and 28 patients (24.8%) developed subclinical HT. Univariate analysis revealed that younger age,mean dose to the thyroid gland,V40,V45,V50,V55,V60 were correlated with developing HT (all P<0.05).On multivariate analysis including patient,tumor,and treatment variables,younger age (P=0.002) and V50(P=0.002) remained statistically significant. We found that the cutoff value of V50(50%) may be an valuable evaluation marker of HT.Combined with age to predict the HT,the area under ROC curve is 0.728.The endpoint event rate of the patients whose level of V50 is above 50% and age level below 45 years were 79.3%,whlie the date in patients whose level of V50 is below 50% and age level above 45 years was 31.8%. Conclusions Thyroid V50 above 50% is predictive of primary HT after IMRT for NPC patient,Our results suggested that restricting V50<50% during IMRT planning may facilitate the reduction in incidence of HT for the younger patients.
. Dosimetric predictors of hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy[J]. Chinese Journal of Radiation Oncology, 2017, 26(10): 1126-1130.
[1] 易俊林,高黎,黄晓东,等.416例鼻咽癌调强放疗远期生存与影响因素分析[J].中华放射肿瘤学杂志,2012,21(3)196-199.DOI:10.3760/cma.j.issn.1004-4221.2012.03.002. Yi JL,Gao L,Huang XD,et al. Nasopharyngeal carcinoma treated by intensity-modulated radiotherapy:long-term results of 416 patients[J].Chin J Radiat Oncol,2012,21(3)196-199.DOI:10.3760/cma.j.issn.1004-4221.2012.03.002. [2] Chyan A,Chen J,Shugard E,et al. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy[J].Radiat Oncol,2014,9:269.DOI:10.1186/s13014-014-0269-4. [3] Murthy V,Narang S,Ghosh-Laskar K,et al. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers:prospective data from 2 randomized controlled trials[J].Head Neck,2014,36(11):1573-1580.DOI:1002/hed.23482. [4] Mercado G,Adelstein DJ,Saxton JP,et al. Hypothyroidism[J].Cancer,2001,92(12):2892-2897. [5] Tell R,Lundell G,Nilsson B,et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-andneck cancer[J].Int J Radiat Oncol Biol Phys,2004,60(2):395-400. [6] Lin Z,Wang X,Xie W,et al. Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients[J].J Med Imaging Radiat Oncol,2013,57(6):713-718.DOI:10.1111/1754-9485.12074. [7] Murthy V,Narang K,Ghosh-Laskar S,et al. Hypothyroidism after 3-dimensional conformal radiotherapy and intensitymodulated radiotherapy for head and neck cancers:prospective data from 2 randomized controlled trials[J].Head Neck,2014,36(11):1573-1880.DOI:10.1002/hed.23482. [8] Wu YH,Wang HM,Chen HH,et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients[J].Int J Radiat Oncol Biol Phys,2010,76(4):1133-1139.DOI:10.1016/j.ijrobp.2009.03.011. [9] Vogelius IR,Bentzen SM,Maraldo MV,et al. Risk factors for radiation-induced hypothyroidism:a literature-based meta-analysis[J].Cancer,2011,117(23):5250-5260.DOI:10.1002/cncr.26186. [10] Sommat K,Ong WS,Hussain A,et al. Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,2017,98(3):574-580.DOI:10.1016/j.ijrobp.2017.03.007. [11] Zhai RP,Kong FF,Du CR,et al. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma:clinical and dosimetric predictors in a prospective cohort study[J].Oral Oncol,2017,68:44-49.DOI:10.1016/j.oraloncology. [12] Sachdev S,Refaat T,Bacchus ID,et al. Thyroid v50 highly predictive of hypothyroidism[J].Am J Clin Oncol,2017,40(4):413-417.DOI:10.1097/COC.0000000000000165. [13] Ling S,Bhatt AD,Brown NV,et al. Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation[J].Head Neck,2017,39(3):548-554.DOI:10.1002/hed.24643. [14] Fan CY1,Lin CS1,Chao HL,et al. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy:a population-based cohort study[J].Radiother Oncol,2017,123(3):394-400.DOI:10.1016/j.radonc.2017.04.025. [15] Wu YH,Wang HM,Chen HH,et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients[J].Int J Radiat Oncol Biol Phys,2010,76(4):1133-1139.DOI:10.1016/j.ijrobp.2009.03.011. [16] Zubizarreta PA,D′Antonio G,Raslawski E,et al. Nasopharyngeal carcinoma in childhood and adolescence:a single-institution experience with combined therapy[J].Cancer,2000,89(3):690-695.
2017, Vol. 26 
